<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Advances in medicine &#187; Ulcerative Colitis</title>
	<atom:link href="http://www.advances-in-medicine.com/category/ulcerative-colitis/feed" rel="self" type="application/rss+xml" />
	<link>http://www.advances-in-medicine.com</link>
	<description></description>
	<lastBuildDate>Thu, 02 Feb 2012 18:12:08 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>REFERENCES</title>
		<link>http://www.advances-in-medicine.com/2008/06/references.html</link>
		<comments>http://www.advances-in-medicine.com/2008/06/references.html#comments</comments>
		<pubDate>Sat, 07 Jun 2008 23:02:11 +0000</pubDate>
		<dc:creator>Alex</dc:creator>
				<category><![CDATA[Ulcerative Colitis]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=52</guid>
		<description><![CDATA[1. Kornbluth AA, Salomon P, Sacks HS, et al. Meta-analysis of the effectiveness of current drug therapy of ulcerative colitis. J Clin Gastroenterol 1993;16:215-8. 2. Meyers S, Janowitz HD. The &#8220;Natural History&#8221; of ulcerative colitis: An analysis of the placebo response. Am J Gastroenterol 1989;11:33-7. 3. Calkins BM. Inflammatory bowel diseases. In: Everhart JE, ed. [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2008/06/references.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RECOMMENDATIONS FOR CANCER SURVEILLANCE</title>
		<link>http://www.advances-in-medicine.com/2008/06/recommendations-for-cancer-surveillance.html</link>
		<comments>http://www.advances-in-medicine.com/2008/06/recommendations-for-cancer-surveillance.html#comments</comments>
		<pubDate>Thu, 05 Jun 2008 22:40:32 +0000</pubDate>
		<dc:creator>Alex</dc:creator>
				<category><![CDATA[Ulcerative Colitis]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=50</guid>
		<description><![CDATA[After 8-10 years of colitis, annual surveillance colonoscopy with multiple biopsies at regular intervals should be performed. The finding of definite dysplasia of any grade, confirmed by expert pathologists&#8217; review, is an indication for colectomy. Patients with UC are at increased risk for colorectal cancer; the degree of risk is related to duration of disease [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2008/06/recommendations-for-cancer-surveillance.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>RECOMMENDATION FOR SURGERY</title>
		<link>http://www.advances-in-medicine.com/2008/06/recommendation-for-surgery.html</link>
		<comments>http://www.advances-in-medicine.com/2008/06/recommendation-for-surgery.html#comments</comments>
		<pubDate>Mon, 02 Jun 2008 13:32:31 +0000</pubDate>
		<dc:creator>Alex</dc:creator>
				<category><![CDATA[Ulcerative Colitis]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=48</guid>
		<description><![CDATA[Absolute indications for surgery are exsanguinating hemorrhage, perforation, and documented or strongly suspected carcinoma. Other indications for surgery are severe colitis with or without toxic megacolon unresponsive to conventional maximal medical therapy, and the patient with less severe, but medically intractable symptoms or intolerable steroid side effects. There are no prospective randomized trials comparing medical [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2008/06/recommendation-for-surgery.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MANAGEMENT OF SEVERE COLITIS</title>
		<link>http://www.advances-in-medicine.com/2008/05/management-of-severe-colitis.html</link>
		<comments>http://www.advances-in-medicine.com/2008/05/management-of-severe-colitis.html#comments</comments>
		<pubDate>Sat, 31 May 2008 23:24:16 +0000</pubDate>
		<dc:creator>Alex</dc:creator>
				<category><![CDATA[Ulcerative Colitis]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=46</guid>
		<description><![CDATA[The patient with severe colitis refractory to maximal oral treatment with prednisone, oral aminosalicylate drugs, and topical medications, or the patient who presents with toxicity, should be treated for 7-10 days with intravenous steroids. Failure to demonstrate significant improvement within 7-10 days is an indication for either colectomy or treatment with intravenous cyclosporine in specialized [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2008/05/management-of-severe-colitis.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MILD-MODERATE EXTENSIVE COLITIS: MAINTENANCE OF REMISSION</title>
		<link>http://www.advances-in-medicine.com/2008/05/mild-moderate-extensive-colitis-maintenance-of-remission.html</link>
		<comments>http://www.advances-in-medicine.com/2008/05/mild-moderate-extensive-colitis-maintenance-of-remission.html#comments</comments>
		<pubDate>Fri, 30 May 2008 00:10:51 +0000</pubDate>
		<dc:creator>Alex</dc:creator>
				<category><![CDATA[Ulcerative Colitis]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=45</guid>
		<description><![CDATA[When the acute attack is controlled, a maintenance regimen is usually required, especially in patients with severe, extensive, or relapsing disease. Sulfasalazine, olsalazine, or mesalamine are all effective in reducing relapses. As a rule, patients should not be treated chronically with steroids. Azathioprine or 6-MP may be useful as steroid-sparing agents for steroid-dependent patients, and [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2008/05/mild-moderate-extensive-colitis-maintenance-of-remission.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MANAGEMENT OF MILD-MODERATE EXTENSIVE COLITIS: ACTIVE DISEASE</title>
		<link>http://www.advances-in-medicine.com/2008/05/management-of-mild-moderate-extensive-colitis-active-disease.html</link>
		<comments>http://www.advances-in-medicine.com/2008/05/management-of-mild-moderate-extensive-colitis-active-disease.html#comments</comments>
		<pubDate>Tue, 27 May 2008 15:50:46 +0000</pubDate>
		<dc:creator>Alex</dc:creator>
				<category><![CDATA[Ulcerative Colitis]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=44</guid>
		<description><![CDATA[Patients with mild to moderate extensive colitis should begin therapy with oral sulfasalazine in daily doses titrated up to 4-6 g/day, or an alternate aminosalicylate in doses up to 4.8 g/day. Oral steroids are generally reserved for patients who are refractory to oral aminosalicylates with or without topical therapy, or for patients whose symptoms are [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2008/05/management-of-mild-moderate-extensive-colitis-active-disease.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>MAINTENANCE OF REMISSION IN DISTAL DISEASE</title>
		<link>http://www.advances-in-medicine.com/2008/05/maintenance-of-remission-in-distal-disease.html</link>
		<comments>http://www.advances-in-medicine.com/2008/05/maintenance-of-remission-in-distal-disease.html#comments</comments>
		<pubDate>Sun, 25 May 2008 18:50:43 +0000</pubDate>
		<dc:creator>Alex</dc:creator>
				<category><![CDATA[Ulcerative Colitis]]></category>

		<guid isPermaLink="false">http://www.advances-in-medicine.com/?p=42</guid>
		<description><![CDATA[Mesalamine suppositories in a dose of 500 mg twice daily are effective in the maintenance of remission, in patients with proctitis, whereas mesalamine enemas (2-4 grams) are effective in patients with distal colitis. Sulfasalazine (2-4 g/day) and mesalamine (1.5-4 g/day) are also effective in maintaining remission, whereas topical corticosteroids, on the other hand, have not [...]]]></description>
		<wfw:commentRss>http://www.advances-in-medicine.com/2008/05/maintenance-of-remission-in-distal-disease.html/feed</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

